NuVision Biotherapies raised €5.5M in a funding round in Feb 2026. The company is based in Nottingham, UK. Investors in the round: Mercia Ventures, Midlands Engine Investment Fund II, Pioneer Group and 1 other. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
